Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Livongo Health, Inc.    LVGO

LIVONGO HEALTH, INC.

(LVGO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • The company has solid fundamentals for a short-term investment strategy.
Strengths
  • The prospective high growth for the next fiscal years is among the main assets of the company
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The tendency within the weekly time frame is positive above the technical support level at 37.96 USD
Weaknesses
  • Technically, the stock approaches a strong medium-term resistance at USD 76.69.
  • Low profitability weakens the company.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
Sector Medical Equipment, Supplies & Distribution - NEC
1st jan.Capitalisation (M$)Investor Rating
LIVONGO HEALTH, INC.200.04%7 355
MEDTRONIC PLC-19.17%122 997
BAXTER INTERNATIONAL INC.2.97%43 811
DEXCOM, INC.85.33%37 437
HOYA CORPORATION-3.01%35 665
TERUMO CORPORATION3.63%28 479
ZIMMER BIOMET HOLDINGS-20.26%24 684
SARTORIUS STEDIM BIOTECH52.34%23 341
ALIGN TECHNOLOGY, INC.-1.65%21 616
AMERISOURCEBERGEN CORPORATI..16.43%20 497
WEST PHARMACEUTICAL SERVICE..51.11%16 720
SYSMEX CORPORATION8.30%15 944
FISHER & PAYKEL HEALTHCARE ..54.01%13 201
STERIS PLC0.67%13 035
AVANTOR, INC.-6.34%9 781
DENTSPLY SIRONA INC.-22.14%9 653
More Results
Financials (USD)
Sales 2020 301 M - -
Net income 2020 -49,1 M - -
Net cash 2020 370 M - -
P/E ratio 2020 -174x
Yield 2020 -
Capitalization 7 355 M 7 355 M -
EV / Sales 2019
EV / Sales 2020 23,2x
Nbr of Employees 671
Free-Float 57,3%
Upcoming event on LIVONGO HEALTH, INC.
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality -
Business Predictability
P/E ratio -
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes